Valeant Pharmaceuticals International (NYSE:VRX)

CAPS Rating: 3 out of 5

A global specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products, primarily in the areas of neurology, infectious disease, and dermatology.

Results 1 - 20 of 41 : 1 2 3 Next »

Recs

0
Member Avatar mlarms (< 20) Submitted: 7/31/2014 2:24:29 AM : Outperform Start Price: $118.88 VRX Score: +8.70

My big Pharma pick

Recs

0
Member Avatar TerryHoodSr (66.61) Submitted: 6/16/2014 10:58:46 AM : Outperform Start Price: $117.81 VRX Score: +9.06

VRX EPS 1YR 60% 3YR 50% 5YR 55%
CURR EPS 2.89 NEXT YR EPS 10.54
NEXT YR PE 11

Recs

0
Member Avatar DrGoldin (99.68) Submitted: 6/16/2014 9:49:48 AM : Outperform Start Price: $117.98 VRX Score: +8.91

It was too high. Now it's too low.

Recs

0
Member Avatar chipotlepickle (98.12) Submitted: 6/15/2014 5:21:26 PM : Underperform Start Price: $118.81 VRX Score: -7.86

Running out of one time events.

Recs

0
Member Avatar ValueSwap (< 20) Submitted: 6/12/2014 3:29:27 PM : Outperform Start Price: $120.02 VRX Score: +6.46

How R&D should work and their aggressive capitalizing interest to generate a low tax rate create much fuzz about the company, which in turn give a long term holder a good entry point

Recs

0
Member Avatar IanERichards (85.97) Submitted: 6/4/2014 7:37:57 AM : Outperform Start Price: $131.15 VRX Score: -3.32

Focus on capital allocation - creative approach to making a deal

Recs

0
Member Avatar RickP (60.42) Submitted: 5/18/2014 6:17:33 PM : Outperform Start Price: $125.85 VRX Score: -1.73

Great CEO......

Fantastic future regardless of whether Allergen merger occurs or not

Recs

0
Member Avatar RLBOWERSOX (96.87) Submitted: 3/31/2014 4:40:45 PM : Outperform Start Price: $132.07 VRX Score: -6.69

One of the final four

Recs

0
Member Avatar mrwrong (< 20) Submitted: 3/29/2014 2:06:48 PM : Underperform Start Price: $129.27 VRX Score: +5.09

growth will stall as company comes a cropper, with a bridge too far. most all- do, but i like it now.

Recs

0
Member Avatar motto1628 (34.28) Submitted: 3/25/2014 4:05:57 PM : Outperform Start Price: $132.26 VRX Score: -7.17

- genius CEO in acquisition
- diversified pharmaceutical products
- stock advisor pick

Recs

0
Member Avatar mtbound (35.12) Submitted: 3/1/2014 12:25:37 PM : Outperform Start Price: $143.30 VRX Score: -16.18

I'm here mainly because of leadership. I've bought in to extraordinary leadership extracting value.

Recs

0
Member Avatar lapinkpanther (58.77) Submitted: 2/24/2014 2:58:06 PM : Outperform Start Price: $145.96 VRX Score: -17.33

Great Management!

Recs

0
Member Avatar bradrimm (52.90) Submitted: 2/9/2014 9:55:01 AM : Outperform Start Price: $138.21 VRX Score: -15.80

Strips dead wood. Value adding. Good macro scene

Recs

0
Member Avatar ejlanders14 (< 20) Submitted: 1/24/2014 11:02:41 PM : Underperform Start Price: $132.48 VRX Score: +12.08

Hmmm...on the balance sheet, MF shows "intangibles" rose 8-fold from 2009 to 2013...really?

Recs

0
Member Avatar chris293 (84.92) Submitted: 1/22/2014 7:16:14 PM : Outperform Start Price: $137.06 VRX Score: -12.79

Everyone wants the newest drugs of course. Even if they don't need them.

Recs

0
Member Avatar GVFool15 (60.97) Submitted: 1/22/2014 3:00:32 PM : Outperform Start Price: $132.51 VRX Score: -9.35

They're becoming a large pharmaceutical company, building an empire of products and people that will propel this company to outperform the market over the next 5 years.

Recs

17
Member Avatar jpimp (< 20) Submitted: 1/10/2014 7:35:06 PM : Outperform Start Price: $131.93 VRX Score: -8.96

My grandfather read an article about Valeant in the Montreal Gazette this morning, after reading the article he is convinced Valeants growth is unrealistic and that they are cooking their books. My grandfather is always wrong… about everything.
I bought 50 shares immediately.

Recs

0
Member Avatar huddaman (98.81) Submitted: 12/31/2013 1:19:29 PM : Outperform Start Price: $117.62 VRX Score: +3.66

One of my top 5 picks from SA 2014 Challenge

Recs

0
Member Avatar possumj (< 20) Submitted: 12/25/2013 3:00:56 PM : Outperform Start Price: $113.51 VRX Score: +7.11

More information on three D printing stocks

Recs

0
Member Avatar mark1969ABC (79.14) Submitted: 12/23/2013 10:39:05 PM : Outperform Start Price: $112.30 VRX Score: +7.88

Growth Company

Results 1 - 20 of 41 : 1 2 3 Next »

Featured Broker Partners


Advertisement